The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.EBI
Vertex Pharmaceuticals
Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activity.EBI
Astrazeneca R&D Boston
Identification and validation of human DNA ligase inhibitors using computer-aided drug design.EBI
University of Maryland
Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.EBI
University of Allahabad
Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.BDB
The Scripps Research Institute
NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.BDB
India Central Drug Research Institute
NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis. Crystal structure of the adenylation domain and identification of novel inhibitors.BDB
India Central Drug Research Institute